AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,099,025 | -6.5% | 254,854 | -3.4% | 0.01% | -16.7% |
| Q2 2023 | $3,313,705 | +15.9% | 263,830 | +2.3% | 0.01% | +20.0% |
| Q1 2023 | $2,859,313 | -5.5% | 257,828 | +4.1% | 0.01% | -16.7% |
| Q4 2022 | $3,024,502 | +17.6% | 247,707 | +0.6% | 0.01% | +20.0% |
| Q3 2022 | $2,571,000 | +84.3% | 246,274 | +307.6% | 0.01% | +400.0% |
| Q4 2020 | $1,395,000 | +241.9% | 60,425 | +36.8% | 0.00% | 0.0% |
| Q1 2020 | $408,000 | -71.3% | 44,166 | -69.8% | 0.00% | 0.0% |
| Q4 2019 | $1,424,000 | +352.1% | 146,237 | +272.8% | 0.00% | – |
| Q3 2019 | $315,000 | -34.8% | 39,226 | +1.4% | 0.00% | – |
| Q2 2019 | $483,000 | -35.4% | 38,689 | -29.7% | 0.00% | -100.0% |
| Q1 2019 | $748,000 | +151.0% | 55,010 | +77.1% | 0.00% | – |
| Q4 2018 | $298,000 | -87.5% | 31,065 | -84.3% | 0.00% | -100.0% |
| Q3 2018 | $2,393,000 | -78.0% | 197,921 | -71.6% | 0.00% | -81.8% |
| Q2 2018 | $10,901,000 | -8.6% | 697,890 | -12.0% | 0.01% | 0.0% |
| Q1 2018 | $11,925,000 | +4.7% | 792,898 | +0.2% | 0.01% | +22.2% |
| Q4 2017 | $11,386,000 | +0.0% | 791,260 | +4.8% | 0.01% | -10.0% |
| Q3 2017 | $11,381,000 | +7538.3% | 754,759 | +6986.9% | 0.01% | – |
| Q3 2015 | $149,000 | -23.2% | 10,650 | -22.3% | 0.00% | – |
| Q2 2015 | $194,000 | -25.4% | 13,710 | -42.7% | 0.00% | – |
| Q1 2015 | $260,000 | -1.5% | 23,940 | -24.5% | 0.00% | – |
| Q4 2014 | $264,000 | +13.3% | 31,700 | -19.1% | 0.00% | – |
| Q3 2014 | $233,000 | – | 39,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |